CLINICAL_TRIALS
ClinicalTrials.gov record update
Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology; Non-interventional, Observational, Prospective Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01626547
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:38.933467+00:00
- Published At
- 2017-03-20T00:00:00+00:00
- Record Updated At
- 2017-03-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Chemotherapy-induced Symptomatic Anaemia", "Solid Tumours", "Malignant Lymphomas", "Multiple Myeloma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-03-20"- protocolSection.identificationModule.nctId
"NCT01626547"- protocolSection.identificationModule.officialTitle
"Biosimilar Retacrit\u2122 (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology; Non-interventional, Observational, Prospective Study"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.